[EN] CYCLOPROPANE DERIVATIVE HAVING BACE1 INHIBITING ACTIVITY<br/>[FR] DÉRIVÉ DE CYCLOPROPANE PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE BACE1
申请人:SHIONOGI & CO
公开号:WO2014010748A1
公开(公告)日:2014-01-16
The present invention relates to compounds of the Formula (I) and (II): wherein each variable is as defined in the specification, pharmaceutically acceptable salts and solvates thereof, as well as use of such compounds as a BACE1 inhibitor. The compounds of the invention are useful as an agent for treating a disease induced by production, secretion and/or deposition of amyloid β protein.
α-ketoglutarate-dependent aryloxyalkanoate dioxygenases (AADs) are repurposed for applications in biocatalytic oxyfunctionalization. Activity profiling of natural AADs enabled the synthesis of four types of α-and β-hydroxy acids with broad scope, high efficiency, and good selectivity.